Table 1.
The clinicopathologic characteristics of the study participants.
| No. | Age | Complications | CA125 | Recurrent pathology | ||
|---|---|---|---|---|---|---|
| Infertility | PCOS | Obesity (BMI, kg/m2) | (U/ml) | |||
| 1 | 31 | No | Yes | No (27.9) | 46.8 | – |
| 2 | 23 | No | Yes | Yes (32.7) | 37.5 | AH2-3 |
| 3 | 31 | No | No | No (22.0) | 56.7 | – |
| 4 | 27 | Yes | No | Yes (31.2) | 27.8 | G2-3 EA |
| 5 | 26 | Yes | Yes | Yes (37.6) | 27.5 | – |
| 6 | 35 | No | No | Yes (30.5) | 32.0 | – |
| 6 | 26 | Yes | Yes | No (29.4) | 40.7 | AH 3 |
| 8 | 22 | No | Yes | No (28.6) | 30.5 | – |
Obesity, BMI ≥ 30 kg/m2; EA, endometrioid adenocarcinoma; AH, atypical hyperplasia; G, grade; PCOS, polycystic ovary syndrome.